Atrial fibrillation fingerprinting; spotting bio‐electrical markers to early recognize atrial fibrillation by the use of a bottom‐up approach (AFFIP): Rationale and design

por Starreveld, Roeliene, Knops, Paul, Ramos, Kennedy S., Roos‐Serote, Maarten C., Bogers, Ad J.J.C., Brundel, Bianca J.J.M., de Groot, Natasja M.S.
Publicado 2020

Screening of novel HSP-inducing compounds to conserve cardiomyocyte function in experimental atrial fibrillation

por van Marion, Denise MS, Hu, Xu, Zhang, Deli, Hoogstra-Berends, Femke, Seerden, Jean-Paul G, Loen, Lizette, Heeres, Andre, Steen, Herman, Henning, Robert H, Brundel, Bianca JJM
Publicado 2019

Mitochondrial Dysfunction Underlies Cardiomyocyte Remodeling in Experimental and Clinical Atrial Fibrillation

por Wiersma, Marit, van Marion, Denise M.S., Wüst, Rob C.I., Houtkooper, Riekelt H., Zhang, Deli, de Groot, Natasja M.S., Henning, Robert H., Brundel, Bianca J.J.M.
Publicado 2019

Cell-Free Circulating Mitochondrial DNA: A Potential Blood-Based Marker for Atrial Fibrillation

por Wiersma, Marit, van Marion, Denise M.S., Bouman, Emma J., Li, Jin, Zhang, Deli, Ramos, Kennedy S., Lanters, Eva A.H., de Groot, Natasja M.S., Brundel, Bianca J.J.M.
Publicado 2020